SCHEMBL31160040

SCHEMBL31160040

CNc1cc(C(=O)OC)cc(OC)c1NC(=O)C(C)Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ KDM4E B2RXH2 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ KMT2A Q03164 5/20 0.39
▸ MAPT P10636 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ CNR2 P34972 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ PYGL P06737 1/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20121418 0.81 MAPT (0.46) POLBHPGDNPSR1KDM4EALDH1A1
SCHEMBL31159930 0.78 KMT2A (0.37) HPGDNPSR1KDM4EALDH1A1KMT2A
SCHEMBL23971107 0.75 CA12 (0.46) HPGDHTTKDM4EALDH1A1KMT2A
SCHEMBL10682199 0.75 MAPT (0.51) POLBHPGDNPSR1KDM4EALDH1A1
SCHEMBL27255559 0.71 KDM4E (0.45) POLBHPGDNPSR1KDM4EALDH1A1
SCHEMBL19826010 0.69 CA12 (0.55) HTTALDH1A1KMT2AMEN1LMNA
SCHEMBL23159630 0.69 CNR2 (0.48) POLBHPGDNPSR1KDM4EALDH1A1
SCHEMBL10676568 0.69 MAPT (0.49) POLBHPGDNPSR1KDM4EALDH1A1
SCHEMBL18940647 0.68 KDM4E (0.49) POLBHPGDNPSR1HTTKDM4E
SCHEMBL27255581 0.68 ALDH1A1 (0.39) NPSR1KDM4EALDH1A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688144-A1 COMPOUNDS AS GLP-1R AGONISTS Terns Pharmaceuticals, Inc. (US) 2026-02-11 — — EP disclosed
WO-2024206878-A1 COMPOUNDS AS GLP-1R AGONISTS TERNS PHARMACEUTICALS, INC. (US) 2024-10-03 — — WO disclosed
Send feedback